Danaher’s point-of-care focused HemoCue subsidiary has launched its newest hemoglobin test in the U.S. following a recent 510(k) clearance from the FDA. The company’s Hb 801 system allows healthcare ...
HemoCue AB report fruitful discussions, continued support and new activities related to health initiatives, following the participation at the High-Level Business Delegation in New Delhi and Mumbai, ...
In conjunction with its plan to refocus on diagnostic informational services, Quest Diagnosticsannounced Wednesday that it plans to sell its HemoCue diagnostic products division. Last month, the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback